These findings collectively underscore the pivotal role for LINC00960 in TNBC and its significant implications in breast cancer prognosis, further underscoring its potential as a valuable prognostic biomarker and therapeutic target in the clinical management of this aggressive subtype. The gene discussed is LINC00960; the disease is breast carcinoma.